脳モニタリング市場 : 2028年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2024年1月

Brain Monitoring Market – Global Forecast to 2028

脳モニタリング市場 : デバイス (EEG、EMG、MEG、ICP、MRI、fMRI、CT) 、付属品 (電極、センサー)、モダリティ (ポータブル、ウェアラブル)、適応症 (脳卒中、外傷性脳損傷、てんかん、頭痛、睡眠)、エンドユーザー (病院、神経科センター) – 2028年までの世界予測
Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) – Global Forecast to 2028

ページ数336
図表数375
種別英文調査報告書
価格

お問合せ・ご注文  価格・納期について

Report Overview

The global brain monitoring market size is estimated to be USD 4.8 billion by 2028, from USD 3.5 billion in 2023, at a CAGR of 6.3%. The brain monitoring market experiences propulsion primarily due to heightened occurrences of neurological disorders, increased awareness regarding neurodegenerative diseases, a surge in traumatic brain injuries, and amplified utilization of brain monitoring in clinical trials. Moreover, the market is set to benefit from escalating demands for non-invasive and minimally invasive devices, the expanding spectrum of therapeutic applications for brain monitoring tools, and the burgeoning healthcare sector in emerging economies.

脳モニタリング市場 : 2028年までの世界予測

Conversely, challenges such as the high expenses associated with complex brain monitoring procedures and devices, unfavorable reimbursement policies, and a shortage of proficient professionals capable of effectively operating brain monitoring devices impede the market’s growth.

“The devices segment is expected to account for the largest brain monitoring devices market share in 2022.”

By product, the global brain monitoring market is categorized into devices and accessories. The devices segment is expected to hold the largest share of the brain monitoring market in 2022. This is primarily attributed to the increasing occurrence of neurological, neurodegenerative, psychotic, and sleep disorders, alongside the imperative for early diagnosis, the presence of innovative portable and wearable monitoring devices designed for home use, and a growing awareness among patients.

脳モニタリング市場 : 2028年までの世界予測 ecosystem

“The electrodes segment to register the highest growth rate in the forecast period.”

The electrodes segment is expected to register the highest growth rate in the forecast period. Technological progress has improved electrode-tissue interfaces, enabling the creation of cost-efficient, high-functioning electrodes within this market. Moreover, the integration of disposable electrodes has significantly propelled their acceptance and the expansion of this market segment.

“The Fixed devices accounted for the largest share of the modality segment of the brain monitoring market.”
By modality, the global brain monitoring market is categorized into fixed, portable, and wearable. The fixed devices held the largest share of the brain monitoring market in 2022. Attributed to their established utilization in clinical environments like hospitals, specialized healthcare centers, and research institutions, these fixed devices are commonly regarded as the benchmark for comprehensive brain monitoring. Their reputation stems from their precision, dependability, and sophisticated features.
The traumatic brain injury segment accounted for the largest share of the brain monitoring market in 2022.
Based on medical condition, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A key factor substantially boosting the market share of this segment is the notable rise in Traumatic Brain Injuries (TBIs) worldwide. This escalation in TBIs generates a considerable need for managing these cases, thereby requiring the widespread use of brain monitoring devices.

“North America to be the largest regional segment in the brain monitoring market during the forecast period.”

Based on the region, the global brain monitoring market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the global brain monitoring market in 2022, while Asia Pacific is projected to be the fastest-growing region in the forecast period. The expansion of the market in Asia stems from several factors, including the expanding elderly population, access to affordable skilled labor, rising disposable incomes, an increased incidence of neurodegenerative disorders, and heightened governmental focus on healthcare reforms within the region.

脳モニタリング市場 : 2028年までの世界予測 region

Breakdown of primaries

The break of primary participants was as mentioned below:

• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

The brain monitoring market is dominated by a few globally established players such as Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Masimo Corporation (US), Unilabs Holdings AB (Sweden), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), Luciole Meidcal AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Integra LifeSciences Corporation (US), and Neurosoft (Russia).

Research Coverage:

The report segments the brain monitoring market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (devices and accessories), Procedure (Invasive, non-invasive), Modality (Fixed, Wearable, Portable), disease type (traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases), end-user (into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end-users),
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the Brain Monitoring market.


Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Brain Monitoring market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
.
o Analysis of key drivers (increasing incidence and prevalence of neurological disorders, rising awareness of neurogenerative disorders, growing incidence of traumatic brain injuries), restraints (high cost of complex brain monitoring procedures and devices, unfavorable reimbursement policies), opportunities (increasing demand of non-invasive and minimally invasive devices), challenges (the shortage of trained professionals to effectively operate brain monitoring devices).
o Market Penetration: Comprehensive information on product portfolios offered by the top players in the global brain monitoring market. The report analyzes this market by products, procedure, modality, medical condition, and end users.
o Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global brain monitoring market
o Market Development: Comprehensive information on the lucrative emerging markets by products, procedure, modality, medical condition, and end users.
o Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global brain monitoring market
o Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global brain monitoring market.

Table of Contents

1            INTRODUCTION            43

1.1         STUDY OBJECTIVES      43

1.2         MARKET DEFINITION   43

1.3         INCLUSIONS & EXCLUSIONS     44

1.4         MARKET SCOPE             45

1.4.1      MARKETS COVERED     45

FIGURE 1           MARKET SEGMENTATION         45

1.4.2      REGIONS COVERED      46

FIGURE 2           REGIONAL SEGMENTATION     46

1.4.3      YEARS CONSIDERED     46

1.4.4      CURRENCY CONSIDERED          47

1.5         STAKEHOLDERS            47

1.6         RESEARCH LIMITATIONS           47

1.6.1      SCOPE-RELATED LIMITATIONS             47

1.6.2      METHODOLOGY-RELATED LIMITATIONS         47

1.7         SUMMARY OF CHANGES            47

1.7.1      IMPACT OF RECESSION 48

2            RESEARCH METHODOLOGY     49

2.1         RESEARCH DATA           49

FIGURE 3           RESEARCH DESIGN       49

2.1.1      SECONDARY DATA       50

2.1.1.1   Key data from secondary sources     50

2.1.2      PRIMARY DATA 51

FIGURE 4           PRIMARY SOURCES       51

2.1.2.1   Key data from primary sources         52

2.1.2.2   Insights from primary experts          53

FIGURE 5           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 53

FIGURE 6           BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION    54

2.2         MARKET SIZE ESTIMATION       54

FIGURE 7           SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS          55

FIGURE 8           COMPANY REVENUE ESTIMATION: NATUS MEDICAL, INC. (2022)   56

FIGURE 9           MARKET REVENUE ESTIMATION: EEG MARKET 56

FIGURE 10         BOTTOM-UP APPROACH           57

FIGURE 11         TOP-DOWN APPROACH             59

FIGURE 12         CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN MONITORING MARKET (2023–2028)     60

FIGURE 13         CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   61

TABLE 1             MARKET ASSESSMENT FACTOR ANALYSIS         62

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          63

FIGURE 14         DATA TRIANGULATION METHODOLOGY         63

2.4         STUDY ASSUMPTIONS  64

2.5         RISK ASSESSMENT         64

TABLE 2             RISK ASSESSMENT: BRAIN MONITORING MARKET         64

2.6         IMPACT OF ECONOMIC RECESSION ON BRAIN MONITORING MARKET              65

3            EXECUTIVE SUMMARY 66

FIGURE 15         BRAIN MONITORING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 66

FIGURE 16         BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2023 VS. 2028 (USD MILLION)     67

FIGURE 17         BRAIN MONITORING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION) 67

FIGURE 18         BRAIN MONITORING MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION) 68

FIGURE 19         BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2023 VS. 2028 (USD MILLION)             68

FIGURE 20         BRAIN MONITORING MARKET, BY END USER, 2023–2028 (USD MILLION)          69

FIGURE 21         REGIONAL SNAPSHOT: BRAIN MONITORING MARKET  70

4            PREMIUM INSIGHTS      71

4.1         BRAIN MONITORING MARKET OVERVIEW         71

FIGURE 22         INCREASING INCIDENCE AND PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET           71

4.2         BRAIN MONITORING MARKET, BY REGION        72

FIGURE 23         NORTH AMERICA TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD     72

4.3         BRAIN MONITORING MARKET, BY PROCEDURE             73

FIGURE 24         NON-INVASIVE PROCEDURES AND JAPAN HELD LARGEST MARKET SHARE IN 2022 73

4.4         GEOGRAPHIC SNAPSHOT: BRAIN MONITORING MARKET          74

FIGURE 25         CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 74

4.5         DEVELOPED VS. EMERGING ECONOMIES: BRAIN MONITORING MARKET            75

FIGURE 26         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD              75

5            MARKET OVERVIEW     76

5.1         INTRODUCTION            76

5.2         MARKET DYNAMICS     76

FIGURE 27         DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BRAIN MONITORING MARKET  76

5.2.1      DRIVERS            77

5.2.1.1   Increasing incidence and prevalence of neurological disorders   77

5.2.1.2   Rising awareness of neurodegenerative disorders         78

5.2.1.3   Growing incidence of traumatic brain injuries              78

5.2.1.4   Increased applications of brain monitoring devices in clinical trials          79

5.2.2      RESTRAINTS     79

5.2.2.1   High cost of complex brain monitoring procedures and devices  79

5.2.2.2   Unfavorable reimbursement policies 80

5.2.3      OPPORTUNITIES           80

5.2.3.1   Increasing demand for non-invasive and minimally-invasive brain monitoring devices   80

5.2.3.2   Expanding therapeutic applications of brain monitoring devices 81

5.2.3.3   Growing healthcare market in emerging economies     81

5.2.4      CHALLENGES   82

5.2.4.1   Shortage of trained medical professionals      82

5.2.4.2   Complex regulatory process and compliance framework            83

5.3         INDUSTRY TRENDS       83

5.3.1      GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE              83

5.3.2      INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY 84

5.4         PRICING ANALYSIS        84

TABLE 3             REGIONAL PRICING ANALYSIS OF KEY BRAIN MONITORING DEVICES            85

TABLE 4             AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2022) 85

5.5         VALUE CHAIN ANALYSIS            86

5.5.1      RESEARCH & PRODUCT DEVELOPMENT            86

5.5.2      RAW MATERIAL PROCUREMENT            86

5.5.3      MANUFACTURING        86

5.5.4      DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES              86

FIGURE 28         VALUE CHAIN ANALYSIS: BRAIN MONITORING MARKET              86

5.6         ECOSYSTEM MARKET/MAP       87

FIGURE 29         ECOSYSTEM MARKET/MAP: BRAIN MONITORING MARKET              87

5.7         PORTER’S FIVE FORCES ANALYSIS         88

TABLE 5             PORTER’S FIVE FORCES ANALYSIS: BRAIN MONITORING MARKET            88

5.7.1      THREAT OF NEW ENTRANTS    88

5.7.2      THREAT OF SUBSTITUTES         88

5.7.3      BARGAINING POWER OF SUPPLIERS     89

5.7.4      BARGAINING POWER OF BUYERS           89

5.7.5      INTENSITY OF COMPETITIVE RIVALRY 89

5.8         TARIFF & REGULATORY ANALYSIS        89

5.8.1      TARIFF FOR BRAIN MONITORING DEVICES       89

5.8.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          90

TABLE 6             LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90

5.8.3      REGULATORY ANALYSIS            91

5.8.3.1   North America     91

5.8.3.1.1 US         91

TABLE 7             US FDA: MEDICAL DEVICE CLASSIFICATION     91

TABLE 8             US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              92

5.8.3.1.2 Canada  92

5.8.3.2   Europe  92

5.8.3.3   Asia Pacific          93

5.8.3.3.1 Japan     93

TABLE 9             JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA              93

5.8.3.3.2 China     93

5.8.3.3.3 India      94

5.9         TECHNOLOGY ANALYSIS           95

5.10       PATENT ANALYSIS        95

5.10.1    PATENT PUBLICATION TRENDS            95

5.10.2    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS            96

FIGURE 30         JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN MONITORING PATENTS, 2011–2023         96

5.10.3    MAJOR PATENTS IN BRAIN MONITORING MARKET       97

FIGURE 31         MAJOR PATENTS FOR BRAIN MONITORING DEVICES (2011–2023)    97

5.11       TRADE ANALYSIS          99

FIGURE 32         PRODUCT IMPORTS UNDER HSN CODE: 901819, BY COUNTRY, 2022 (USD THOUSAND) 100

FIGURE 33         PRODUCT EXPORTS UNDER HSN CODE 901819, BY COUNTRY, 2022 (USD THOUSAND) 100

5.12       CASE STUDY ANALYSIS 101

TABLE 10           CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA DIRECTLY INTO MEDTRONIC CARE MANAGEMENT SERVICES’ (MCMS) BRAIN MONITORING PLATFORM           101

TABLE 11           CASE STUDY 2: EPI-MINDER: A NOVEL IMPLANTABLE DEVICE FOR EPILEPSY MONITORING AND PREDICTION             101

5.13       KEY CONFERENCES & EVENTS, 2023–2024           102

TABLE 12           LIST OF KEY CONFERENCES & EVENTS IN BRAIN MONITORING MARKET, 2023–2024       102

5.14       KEY STAKEHOLDERS & BUYING CRITERIA          103

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         103

TABLE 13           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES 103

TABLE 14           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BRAIN MONITORING DEVICES AND ACCESSORIES, BY TYPE      103

5.14.2    BUYING CRITERIA         104

FIGURE 34         KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES, BY TYPE    104

TABLE 15           KEY BUYING CRITERIA FOR BRAIN MONITORING DEVICES              104

5.15       UNMET NEEDS ANALYSIS & END USER EXPECTATIONS 104

TABLE 16           UNMET NEEDS IN BRAIN MONITORING MARKET           105

5.15.1    END USER EXPECTATIONS        105

TABLE 17           END USER EXPECTATIONS IN BRAIN MONITORING MARKET              106

5.16       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 107

FIGURE 35         REVENUE SHIFTS AND NEW REVENUE POCKETS FOR BRAIN MONITORING MARKET 107

5.17       REIMBURSEMENT SCENARIO ANALYSIS             107

TABLE 18           CPT CODES AND REIMBURSEMENT ANALYSIS IN BRAIN MONITORING MARKET IN US    108

5.18       BUSINESS MODEL ANALYSIS     111

5.19       INVESTMENT AND FUNDING SCENARIO            112

FIGURE 36         INVESTOR DEALS AND FUNDING FOR BRAIN MONITORING DEVICES INCREASED IN 2022     112

FIGURE 37         VALUATION OF KEY FIRMS IN BRAIN MONITORING MARKET IN 2022 (USD MILLION) 112

6            BRAIN MONITORING MARKET, BY PRODUCT    113

6.1         INTRODUCTION            114

TABLE 19           BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          114

6.2         DEVICES            114

TABLE 20           BRAIN MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)          115

TABLE 21           BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)     115

6.2.1      EEG DEVICES   116

6.2.1.1   Growing R&D in cerebral and spinal disorders and increasing number of EEG laboratories to drive segment           116

TABLE 22           EEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          117

6.2.2      TCD DEVICES   117

6.2.2.1   Rising prevalence of strokes and cerebrovascular disorders to aid market growth              117

TABLE 23           TCD DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          118

6.2.3      MEG DEVICES  118

6.2.3.1   High implementation and maintenance costs to limit market     118

TABLE 24           MEG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          119

6.2.4      ICP MONITORS 119

6.2.4.1   Increasing incidence of traumatic brain injuries and post-surgical cerebrovascular complications to propel market        119

TABLE 25           ICP MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          120

6.2.5      CEREBRAL OXIMETERS 120

6.2.5.1   Increasing cases of hypoxia during surgical procedures to drive segment  120

TABLE 26           CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121

6.2.6      MRI SCANNERS 122

6.2.6.1   Technological advancements and rising number of neurological disorders to propel segment    122

TABLE 27           MRI SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          123

6.2.7      CT SCANNERS  123

6.2.7.1   Increasing preference for brain disease progression monitoring to drive segment              123

TABLE 28           CT SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          124

6.2.8      PET SCANNERS 124

6.2.8.1   Rising incidence of cancer to support market growth   124

TABLE 29           PET SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          125

6.2.9      SLEEP MONITORING DEVICES  125

6.2.9.1   Rising prevalence of sleep disorders to boost market growth      125

TABLE 30           SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     126

6.2.10    EMG DEVICES  126

6.2.10.1 Increasing prevalence of neuromuscular diseases to aid market growth    126

TABLE 31           EMG DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          127

6.3         ACCESSORIES   128

TABLE 32           BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)    128

6.3.1      BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE       129

TABLE 33           BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)          129

6.3.1.1   Electrodes           129

TABLE 34           ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          130

6.3.1.1.1 Wet electrodes     130

6.3.1.1.1.1           Flexibility and high quality of signal recording to drive segment 130

TABLE 35           WET ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          131

6.3.1.1.2 Dry electrodes     131

6.3.1.1.2.1           Technological advancements and no requirement for skin preparation to aid market growth              131

TABLE 36           DRY ELECTRODES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          132

6.3.1.1.3 Needle electrodes 132

6.3.1.1.3.1           More accurate signals for diagnostic and therapeutic interventions to support market growth       132

TABLE 37           NEEDLE ELECTRODES MARKET, BY REGION, 2021–2028 (USD MILLION)          133

6.3.1.2   Sensors  133

6.3.1.2.1 Increasing patient preference for non-invasive procedures to drive market              133

TABLE 38           SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              134

6.3.1.3   Pastes & gels        134

6.3.1.3.1 Increasing demand for non-invasive methods of brain monitoring to aid market growth   134

TABLE 39           PASTES & GELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          135

6.3.1.4   Caps      135

6.3.1.4.1 Extended application of Infacaps for premature babies to propel segment 135

TABLE 40           CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)  136

6.3.1.5   Batteries 136

6.3.1.5.1 Increasing usage of portable and rechargeable devices to support segment growth              136

TABLE 41           BATTERIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              137

6.3.1.6   Cables   137

6.3.1.6.1 Technological developments for increasing capabilities and cable lifespan to drive segment 137

TABLE 42           CABLES MARKET, BY REGION, 2021–2028 (USD MILLION)              138

6.3.1.7   Other accessories 138

TABLE 43           OTHER ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          139

6.3.2      BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY              139

TABLE 44           BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   139

6.3.2.1   Disposable accessories       140

6.3.2.1.1 Growing physician preference for disposable accessories to propel market              140

TABLE 45           DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140

6.3.2.2   Non-disposable accessories 141

6.3.2.2.1 Increased usage of reusable accessories in emerging economies to boost segment growth   141

TABLE 46           NON-DISPOSABLE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     141

7            BRAIN MONITORING MARKET, BY PROCEDURE             142

7.1         INTRODUCTION            143

TABLE 47           BRAIN MONITORING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 143

7.1.1      NON-INVASIVE PROCEDURES   143

7.1.1.1   Limited risk of infections and hemorrhage to drive market         143

TABLE 48           BRAIN MONITORING MARKET FOR NON-INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)             144

7.1.2      INVASIVE PROCEDURES             144

7.1.2.1   Higher resolution imaging and detailed disease information to propel market              144

TABLE 49           BRAIN MONITORING MARKET FOR INVASIVE PROCEDURES, BY COUNTRY, 2021–2028 (USD MILLION)            145

8            BRAIN MONITORING MARKET, BY MODALITY  146

8.1         INTRODUCTION            147

TABLE 50           BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)          147

8.2         FIXED DEVICES 147

8.2.1      HIGH ACCURACY, MORE RELIABILITY, AND BETTER DIAGNOSIS TO AID MARKET GROWTH 147

TABLE 51           BRAIN MONITORING MARKET FOR FIXED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)    148

8.3         PORTABLE DEVICES     148

8.3.1      INCREASED MOBILITY AND COMFORT TO PROPEL MARKET GROWTH              148

TABLE 52           BRAIN MONITORING MARKET FOR PORTABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)    149

8.4         WEARABLE DEVICES     149

8.4.1      GREATER CONVENIENCE AND CONTINUOUS DATA COLLECTION TO DRIVE MARKET GROWTH          149

TABLE 53           BRAIN MONITORING MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)    150

9            BRAIN MONITORING MARKET, BY MEDICAL CONDITION          151

9.1         INTRODUCTION            152

TABLE 54           COMPANIES OFFERING DEVICES FOR DIFFERENT MEDICAL CONDITIONS    152

TABLE 55           BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)          152

9.2         TRAUMATIC BRAIN INJURY       153

9.2.1      GROWING INCIDENCE ACROSS ALL AGE GROUPS TO DRIVE MARKET              153

TABLE 56          BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2021–2028 (USD MILLION)            154

9.3         STROKE             154

9.3.1      GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH 154

TABLE 57           BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2021–2028 (USD MILLION)          155

9.4         DEMENTIA        156

9.4.1      FAVORABLE GOVERNMENT INITIATIVES AND INCREASED ACCESS TO TREATMENT TO DRIVE MARKET           156

TABLE 58           BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2021–2028 (USD MILLION)          157

9.5         HEADACHE DISORDERS             157

9.5.1      RISING NUMBER OF INITIATIVES FOR HEADACHE DISORDERS TO PROPEL MARKET          157

TABLE 59           BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)            158

9.6         SLEEP DISORDERS        159

9.6.1      INCREASED STRESS AND UNHEALTHY LIFESTYLES AMONG ADULTS TO DRIVE MARKET       159

TABLE 60           BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION)    160

9.7         PARKINSON’S DISEASE 160

9.7.1      INCREASING GERIATRIC POPULATION TO AID MARKET GROWTH              160

TABLE 61           BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)    161

9.8         EPILEPSY           161

9.8.1      RISING OCCURRENCE OF EPILEPSY AMONG ALL AGE GROUPS TO SUPPORT MARKET GROWTH    161

TABLE 62           BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2021–2028 (USD MILLION)          162

9.9         HUNTINGTON’S DISEASE          162

9.9.1      AVAILABILITY OF ADVANCED TREATMENT AND ONGOING RESEARCH TO AID MARKET GROWTH  162

TABLE 63           BRAIN MONITORING MARKET FOR HUNTINGTON’S DISEASE, BY COUNTRY, 2021–2028 (USD MILLION)            163

9.10       OTHER MEDICAL CONDITIONS 163

TABLE 64           BRAIN MONITORING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2021–2028 (USD MILLION) 164

10          BRAIN MONITORING MARKET, BY END USER    165

10.1       INTRODUCTION            166

TABLE 65           BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)          166

10.2       HOSPITALS       167

10.2.1    HOSPITALS TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD       167

TABLE 66           BRAIN MONITORING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)          168

10.3       NEUROLOGY CENTERS 168

10.3.1    PRESENCE OF HIGHLY EFFICIENT AND ADVANCED BRAIN MONITORING DEVICES TO PROPEL MARKET   168

TABLE 67           BRAIN MONITORING MARKET FOR NEUROLOGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)            169

10.4       DIAGNOSTIC CENTERS 169

10.4.1    FOCUS ON EARLY DIAGNOSIS AND TREATMENT OF NEUROGENERATIVE DISORDERS TO SUPPORT MARKET GROWTH        169

TABLE 68           BRAIN MONITORING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)    170

10.5       AMBULATORY SURGERY CENTERS & CLINICS   170

10.5.1    COST-EFFECTIVE AND MORE CONVENIENT TREATMENT OPTIONS TO AID MARKET GROWTH        170

TABLE 69           BRAIN MONITORING MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)  171

10.6       OTHER END USERS        171

TABLE 70           BRAIN MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)    172

11          BRAIN MONITORING MARKET, BY REGION        173

11.1       INTRODUCTION            174

TABLE 71           BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)          174

11.2       NORTH AMERICA          174

FIGURE 38         NORTH AMERICA: BRAIN MONITORING MARKET SNAPSHOT              175

TABLE 72           NORTH AMERICA: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    175

TABLE 73           NORTH AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   176

TABLE 74           NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)   176

TABLE 75           NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         177

TABLE 76           NORTH AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177

TABLE 77           NORTH AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             177

TABLE 78           NORTH AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)    178

TABLE 79           NORTH AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  178

TABLE 80           NORTH AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 179

TABLE 81           NORTH AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)             179

11.2.1    NORTH AMERICA: RECESSION IMPACT 180

11.2.2    US         180

11.2.2.1 US to dominate North American brain monitoring market during forecast period              180

TABLE 82           US: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 181

TABLE 83           US: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          181

TABLE 84          US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)          182

TABLE 85           US: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)              182

TABLE 86           US: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   182

TABLE 87           US: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             183

TABLE 88           US: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 183

TABLE 89           US: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)          183

TABLE 90           US: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 184

11.2.3    CANADA            184

11.2.3.1 Increasing number of hospitals and surgical centers to propel market       184

TABLE 91           CANADA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     185

TABLE 92           CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)             185

TABLE 93           CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)       186

TABLE 94           CANADA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          186

TABLE 95           CANADA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)           186

TABLE 96           CANADA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             187

TABLE 97           CANADA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     187

TABLE 98           CANADA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 187

TABLE 99           CANADA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     188

11.3       EUROPE             188

FIGURE 39         EUROPE: BRAIN MONITORING MARKET SNAPSHOT      189

TABLE 100         EUROPE: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     190

TABLE 101         EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     190

TABLE 102         EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)             191

TABLE 103         EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             191

TABLE 104         EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          192

TABLE 105         EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   192

TABLE 106         EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             192

TABLE 107         EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     193

TABLE 108         EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 193

TABLE 109         EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     194

11.3.1    EUROPE: RECESSION IMPACT   194

11.3.2    GERMANY         194

11.3.2.1 Growing geriatric population and increasing life expectancy to aid market growth              194

TABLE 110         GERMANY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     195

TABLE 111         GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)             195

TABLE 112         GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)       196

TABLE 113         GERMANY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          196

TABLE 114         GERMANY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)           196

TABLE 115         GERMANY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             197

TABLE 116         GERMANY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)          197

TABLE 117         GERMANY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 197

TABLE 118         GERMANY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     198

11.3.3    FRANCE             198

11.3.3.1 Increasing prevalence of neurological disorders to drive market 198

TABLE 119         FRANCE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     199

TABLE 120         FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)             199

TABLE 121         FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             200

TABLE 122         FRANCE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          200

TABLE 123         FRANCE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   200

TABLE 124         FRANCE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             201

TABLE 125         FRANCE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     201

TABLE 126         FRANCE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 201

TABLE 127         FRANCE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     202

11.3.4    UK         202

11.3.4.1 Increasing R&D investments by public and private sectors to boost market growth              202

TABLE 128         UK: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 203

TABLE 129         UK: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          203

TABLE 130        UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)          204

TABLE 131         UK: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          204

TABLE 132         UK: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   204

TABLE 133         UK: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             205

TABLE 134         UK: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION) 205

TABLE 135         UK: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)          205

TABLE 136         UK: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 206

11.3.5    ITALY   206

11.3.5.1 Rising incidence of neurological disorders in aging population to drive market              206

TABLE 137         ITALY: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 206

TABLE 138         ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          207

TABLE 139         ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             207

TABLE 140         ITALY: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          208

TABLE 141         ITALY: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   208

TABLE 142         ITALY: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             208

TABLE 143         ITALY: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     209

TABLE 144         ITALY: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 209

TABLE 145         ITALY: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 210

11.3.6    SPAIN   210

11.3.6.1 Increased burden of Parkinson’s disease to propel market          210

TABLE 146         SPAIN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210

TABLE 147         SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          211

TABLE 148         SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             211

TABLE 149         SPAIN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          212

TABLE 150         SPAIN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   212

TABLE 151         SPAIN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             212

TABLE 152         SPAIN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     213

TABLE 153         SPAIN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 213

TABLE 154         SPAIN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 214

11.3.7    REST OF EUROPE           214

TABLE 155         REST OF EUROPE: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   215

TABLE 156        REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)       215

TABLE 157         REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         216

TABLE 158         REST OF EUROPE: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216

TABLE 159         REST OF EUROPE: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             216

TABLE 160        REST OF EUROPE: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)       217

TABLE 161         REST OF EUROPE: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  217

TABLE 162         REST OF EUROPE: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 217

TABLE 163         REST OF EUROPE: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)             218

11.4       ASIA PACIFIC    218

TABLE 164         ASIA PACIFIC: BRAIN MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          218

TABLE 165         ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          219

TABLE 166         ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)             219

TABLE 167         ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         220

TABLE 168         ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          220

TABLE 169         ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             220

TABLE 170         ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             221

TABLE 171         ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)          221

TABLE 172         ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 221

TABLE 173         ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)          222

11.4.1    ASIA PACIFIC: RECESSION IMPACT        222

11.4.2    JAPAN  222

11.4.2.1 High incidence of neurological disorders and large geriatric population to drive market   222

TABLE 174         JAPAN: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     223

TABLE 175         JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          223

TABLE 176         JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             224

TABLE 177         JAPAN: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          224

TABLE 178         JAPAN: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   224

TABLE 179         JAPAN: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             225

TABLE 180         JAPAN: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     225

TABLE 181         JAPAN: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 225

TABLE 182         JAPAN: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 226

11.4.3    CHINA  226

11.4.3.1 Increasing number of government initiatives and growing incidence of neurological disorders to drive market            226

TABLE 183         CHINA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     227

TABLE 184         CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          227

TABLE 185         CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             228

TABLE 186         CHINA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          228

TABLE 187         CHINA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   228

TABLE 188         CHINA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             229

TABLE 189         CHINA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     229

TABLE 190         CHINA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 229

TABLE 191         CHINA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     230

11.4.4    INDIA   230

11.4.4.1 Improving healthcare infrastructure and rising public-private investment to support market growth       230

TABLE 192         INDIA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 230

TABLE 193         INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          231

TABLE 194         INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             231

TABLE 195         INDIA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          232

TABLE 196         INDIA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   232

TABLE 197         INDIA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             232

TABLE 198         INDIA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     233

TABLE 199         INDIA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 233

TABLE 200         INDIA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 234

11.4.5    REST OF ASIA PACIFIC  234

TABLE 201         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   234

TABLE 202         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)   235

TABLE 203         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         235

TABLE 204         REST OF ASIA PACIFIC: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)     236

TABLE 205         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             236

TABLE 206         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)    236

TABLE 207         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  237

TABLE 208         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)          237

TABLE 209         REST OF ASIA PACIFIC: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)             238

11.5       LATIN AMERICA             238

TABLE 210         LATIN AMERICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)          239

TABLE 211         LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          239

TABLE 212         LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)       239

TABLE 213         LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         240

TABLE 214         LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 240

TABLE 215         LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             240

TABLE 216         LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)       241

TABLE 217         LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  241

TABLE 218         LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 241

TABLE 219         LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)          242

11.5.1    LATIN AMERICA: RECESSION IMPACT   242

11.5.2    BRAZIL 242

11.5.2.1 High cost of brain monitoring and imaging modalities to limit market growth              242

TABLE 220         BRAZIL: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     243

TABLE 221         BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)          243

TABLE 222         BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             244

TABLE 223         BRAZIL: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          244

TABLE 224         BRAZIL: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   244

TABLE 225         BRAZIL: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             245

TABLE 226         BRAZIL: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     245

TABLE 227         BRAZIL: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 245

TABLE 228         BRAZIL: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     246

11.5.3    MEXICO             246

11.5.3.1 Low tax rates and strong healthcare infrastructure to support market growth              246

TABLE 229         MEXICO: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     247

TABLE 230         MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)             247

TABLE 231         MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)             248

TABLE 232         MEXICO: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          248

TABLE 233         MEXICO: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)   248

TABLE 234         MEXICO: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)             249

TABLE 235         MEXICO: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)     249

TABLE 236         MEXICO: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 249

TABLE 237         MEXICO: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)     250

11.5.4    REST OF LATIN AMERICA          250

TABLE 238         REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   251

TABLE 239         REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)   251

TABLE 240         REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         252

TABLE 241         REST OF LATIN AMERICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          252

TABLE 242         REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             252

TABLE 243         REST OF LATIN AMERICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)    253

TABLE 244         REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  253

TABLE 245         REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)          253

TABLE 246         REST OF LATIN AMERICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)    254

11.6       MIDDLE EAST & AFRICA             254

TABLE 247         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION)       255

TABLE 248         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   255

TABLE 249         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)   255

TABLE 250         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         256

TABLE 251         MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)          256

TABLE 252         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             256

TABLE 253         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)    257

TABLE 254         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  257

TABLE 255         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION)          257

TABLE 256         MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)    258

11.6.1    MIDDLE EAST & AFRICA: RECESSION IMPACT   258

11.6.2    GCC COUNTRIES           258

11.6.2.1 Rising prevalence of Alzheimer’s and increasing number of government initiatives to drive market    258

TABLE 257         GCC COUNTRIES: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   259

TABLE 258        GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)       259

TABLE 259         GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)         260

TABLE 260         GCC COUNTRIES: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION) 260

TABLE 261         GCC COUNTRIES: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)             260

TABLE 262        GCC COUNTRIES: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)       261

TABLE 263         GCC COUNTRIES: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)  261

TABLE 264         GCC COUNTRIES: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 261

TABLE 265        GCC COUNTRIES: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)          262

11.6.3    REST OF MIDDLE EAST & AFRICA           262

TABLE 266         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        262

TABLE 267         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)       263

TABLE 268         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)            263

TABLE 269         REST OF MIDDLE EAST & AFRICA: ELECTRODES MARKET, BY TYPE, 2021–2028 (USD MILLION)             264

TABLE 270         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR ACCESSORIES, BY USABILITY, 2021–2028 (USD MILLION)  264

TABLE 271         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)       264

TABLE 272         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MODALITY, 2021–2028 (USD MILLION)       265

TABLE 273         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY MEDICAL CONDITION, 2021–2028 (USD MILLION) 265

TABLE 274         REST OF MIDDLE EAST & AFRICA: BRAIN MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION)         266

12          COMPETITIVE LANDSCAPE       267

12.1       INTRODUCTION            267

12.2       KEY STRATEGIES/RIGHT TO WIN           267

TABLE 275         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAIN MONITORING MARKET  267

12.3       REVENUE SHARE ANALYSIS       269

12.4       MARKET SHARE ANALYSIS         270

FIGURE 41         MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022            270

TABLE 276         DEGREE OF COMPETITION IN BRAIN MONITORING MARKET              271

FIGURE 42         RANKING OF KEY COMPANIES IN BRAIN MONITORING MARKET, 2022  271

12.5       COMPANY EVALUATION MATRIX          272

12.5.1    STARS  272

12.5.2    EMERGING LEADERS    273

12.5.3    PERVASIVE PLAYERS     273

12.5.4    PARTICIPANTS 273

FIGURE 43         COMPANY EVALUATION MATRIX, 2022 273

12.5.5    COMPANY FOOTPRINT 274

12.5.5.1 Overall footprint  274

TABLE 277         BRAIN MONITORING MARKET: OVERALL FOOTPRINT  274

12.5.5.2 Product footprint 275

TABLE 278         BRAIN MONITORING MARKET: PRODUCT FOOTPRINT 275

12.5.5.3 Procedure footprint           276

TABLE 279         BRAIN MONITORING MARKET: PROCEDURE FOOTPRINT              276

12.5.5.4 Modality footprint             277

TABLE 280         BRAIN MONITORING MARKET: MODALITY FOOTPRINT              277

12.5.5.5 Medical condition footprint             278

TABLE 281         BRAIN MONITORING MARKET: MEDICAL CONDITION FOOTPRINT      278

12.5.5.6 End user footprint             279

TABLE 282         BRAIN MONITORING MARKET: END USER FOOTPRINT 279

12.5.5.7 Regional footprint              280

TABLE 283         BRAIN MONITORING MARKET: REGIONAL FOOTPRINT 280

12.6       START-UP/SME EVALUATION MATRIX 281

12.6.1    PROGRESSIVE COMPANIES       281

12.6.2    RESPONSIVE COMPANIES          281

12.6.3    DYNAMIC COMPANIES 281

12.6.4    STARTING BLOCKS       281

FIGURE 44         START-UP/SME EVALUATION MATRIX, 2022      282

12.6.5    COMPETITIVE BENCHMARKING            282

TABLE 284         DETAILED LIST OF KEY START-UPS/SMES IN BRAIN MONITORING MARKET 282

12.7       COMPETITIVE SCENARIO          283

12.7.1    PRODUCT LAUNCHES & APPROVALS    283

TABLE 285         BRAIN MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, 2020–2024 283

12.7.2    DEALS  285

TABLE 286         BRAIN MONITORING MARKET: DEALS, 2020–2024           285

12.7.3    OTHER DEVELOPMENTS           286

TABLE 287         BRAIN MONITORING MARKET: OTHER DEVELOPMENTS, 2020–2024      286

13          COMPANY PROFILES    287

13.1       KEY PLAYERS   287

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

13.1.1    NATUS MEDICAL INCORPORATED        287

TABLE 289         NATUS MEDICAL INCORPORATED: DEALS, 2020–2024   290

13.1.2    NIHON KOHDEN CORPORATION           291

TABLE 290         NIHON KOHDEN CORPORATION: COMPANY OVERVIEW              291

FIGURE 45         NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)              292

TABLE 291         NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES &

APPROVALS, 2020–2024 293

13.1.3    PHILIPS HEALTHCARE 294

TABLE 292         PHILIPS HEALTHCARE: COMPANY OVERVIEW  294

FIGURE 46         PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)    295

TABLE 293         PHILIPS HEALTHCARE: DEALS, 2020–2024           297

13.1.4    GE HEALTHCARE          298

TABLE 294         GE HEALTHCARE: COMPANY OVERVIEW           298

FIGURE 47         GE HEALTHCARE: COMPANY SNAPSHOT (2022)             299

TABLE 295         GE HEALTHCARE: DEALS, 2020–2024      301

13.1.5    SIEMENS HEALTHINEERS AG    303

TABLE 296         SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW     303

FIGURE 48         SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)              304

TABLE 297         SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, 2020–2024 305

TABLE 298         SIEMENS HEALTHINEERS AG: DEALS, 2020–2024 306

13.1.6    COMPUMEDICS LIMITED          307

TABLE 299         COMPUMEDICS LIMITED: COMPANY OVERVIEW           307

FIGURE 49         COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022)              307

TABLE 300         COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS, 2020–2024 310

TABLE 301         COMPUMEDICS LIMITED: DEALS, 2020–2024      310

13.1.7    MEDTRONIC     311

TABLE 302         MEDTRONIC: COMPANY OVERVIEW     311

FIGURE 50         MEDTRONIC: COMPANY SNAPSHOT (2023)       312

13.1.8    EDWARDS LIFESCIENCES CORPORATION          314

TABLE 303         EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW        314

FIGURE 51         EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)          315

13.1.9    ADVANCED BRAIN MONITORING, INC. 318

TABLE 304         ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW              318

13.1.10  CADWELL INDUSTRIES, INC.     319

TABLE 305         CADWELL INDUSTRIES, INC: COMPANY OVERVIEW       319

TABLE 306         CADWELL INDUSTRIES, INC.: PRODUCT LAUNCHES & APPROVALS, 2020–2024 320

TABLE 307         CADWELL INDUSTRIES, INC.: DEALS, 2020–2024 320

13.1.11  NEUROWAVE SYSTEMS, INC.     321

TABLE 308         NEUROWAVE SYSTEMS, INC.: COMPANY OVERVIEW      321

13.1.12  NEUROSOFT     322

TABLE 309         NEUROSOFT: COMPANY OVERVIEW     322

13.1.13  CGX      324

TABLE 310         CGX: COMPANY OVERVIEW      324

TABLE 311         CGX: OTHER DEVELOPMENTS, 2020–2024           324

13.1.14  NONIN 325

TABLE 312         NONIN: COMPANY OVERVIEW  325

13.1.15  RIMED  326

TABLE 313         RIMED: COMPANY OVERVIEW  326

TABLE 314         RIMED: DEALS, 2020–2024           326

13.1.16  EMOTIV             327

TABLE 315         EMOTIV: COMPANY OVERVIEW             327

13.1.17  DRÄGERWERK AG & CO. KGAA 328

TABLE 316         DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW  328

FIGURE 52         DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)              328

13.1.18  MASIMO CORPORATION            330

TABLE 317         MASIMO CORPORATION: COMPANY OVERVIEW            330

FIGURE 53         MASIMO CORPORATION: COMPANY SNAPSHOT (2021) 330

TABLE 318         MASIMO CORPORATION: DEALS, 2020–2024       331

13.1.19  LUCIOLE MEDICAL AG 332

TABLE 319         LUCIOLE MEDICAL AG: COMPANY OVERVIEW  332

TABLE 320         LUCIOLE MEDICAL AG: DEALS, 2020–2024          333

13.1.20  INTEGRA LIFESCIENCES            334

TABLE 321         INTEGRA LIFESCIENCES: COMPANY OVERVIEW             334

FIGURE 54         INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT (2022) 335

13.2       OTHER PLAYERS           336

13.2.1    INFRASCAN, INC.            336

13.2.2    NEUSOFT MEDICAL SYSTEMS CO., LTD.             337

13.2.3    NORAXON USA 338

13.2.4    STERNMED GMBH         339

13.2.5    CERIBELL          339

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14          APPENDIX         340

14.1       DISCUSSION GUIDE      340

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             345

14.3       CUSTOMIZATION OPTIONS      347

14.4       RELATED REPORTS       347

14.5       AUTHOR DETAILS         348